Formule Prostate - Si miao qian lie wan
Food supplement declared in France, declaration No 2023-8-464, decision dated 9 August 2023
Formule Prostate - Si miao qian lie wan, from Calebasse, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Citrus aurantium 660 mg per day, Lindera aggregata 660 mg per day, Artemisia vulgaris 360 mg per day, Atractylodes lancea 330 mg per day, Coix lacryma-jobi 330 mg per day. 4 rules of use apply to its ingredients (limits and warnings).
- Brand
- not provided
- Food business operator placing the product on the market
- Calebasse
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 3 g
- Directions for use
- 3g soit 6 gélules
- Not recommended (according to the manufacturer)
- Adolescents (under 18), Breastfeeding women, Children (under 12), Young children (aged 1 to 3), Pregnant women, High blood pressure, Infants (under 1 year), Heart problems, Liver problems, Taking anticoagulants, Taking diabetes medication, Taking blood pressure medication, Taking medication
- Objectives stated by the manufacturer (these are not authorised claims)
- Urinary system
Declaration 312530, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Citrus aurantium L. | Péricarpe | Extrait sec aqueux | 660 mg |
| Lindera aggregata (Sims) Kosterm. | Racine | Extrait sec aqueux | 660 mg |
| Artemisia vulgaris L. | Parties aériennes | Extrait sec aqueux | 360 mg |
| Atractylodes lancea (Thunb.) DC. | Rhizome | Extrait sec aqueux | 330 mg |
| Coix lacryma-jobi L. | Graine | Extrait sec aqueux | 330 mg |
| Cyathula officinalis K.C.Kuan | Racine | Extrait sec aqueux | 330 mg |
| Phellodendron amurense Rupr. | Ecorce | Extrait sec aqueux | 330 mg |
Additives
E1204
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Déconseillé aux personnes sous traitement antidiabétique, sous traitement contre l’hypertension, sous traitement anticoagulants ou de traitement cardiaque, consultez votre médecin ou pharmacien. Déconseillé aux personnes présentant de troubles hépatiques. Prendre conseil auprès d'un professionnel de la santé si vous suivez un traitement médicamenteux. La caféine et les sources de caféine ne sont pas autorisées dans les compléments alimentaires contenant Citrus aurantium L.
Regulatory points
- Conditions légales
Artemisia vulgaris L.: L'huile essentielle de cette plante est interdite.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Conditions légales
Citrus aurantium L.: La quantité ingérée de p-synéphrine doit être inférieure à 20 mg par dose journalière recommandée. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants, aux femmes enceintes ou allaitantes et en cas de traitement anti-hypertenseur. La caféine et les sources de caféine ne sont pas autorisées dans les compléments alimentaires contenant Citrus aurantium L.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Conditions légales
Cyathula officinalis K.C.Kuan: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Conditions légales
Phellodendron amurense Rupr.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Artemisia vulgaris L.
Read the warning, when it applies and the studies cited
MUGWORT - ARTEMISIA VULGARIS
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Do not use if you are pregnant or breastfeeding (Brinker 2010; Blumenthal et al. 1998; Williamson et al. 1988).
Sources cited by Health Canada (3)
- Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Riggins C, Rister R, editors. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin (TX): American Botanical Council; 1998.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Williamson EM, Evans FJ, Wren RC. Potter's New Cyclopaedia of Botanical Drugs and Preparations. Saffron Walden (UK): C.W. Daniel Company Limited; 1988.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Brinker 2010; Wichtl 2004; Hoffmann 2003).
Sources cited by Health Canada (3)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.
- Wichtl M, editor. Herbal Drugs and Phytopharmaceuticals: A Handbook for Practice on a Scientific Basis, 3rd edition. Stuttgart (D): Medpharm GmbH Scientific Publishers; 2004.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Formule Prostate - Si miao qian lie wan Laboratoire Calebasse, declared in 2023 : different composition: 0 ingredient(s) added, 1 missing
- Formule Prostate - Si miao qian lie wan Calebasse, declared in 2021, earlier declaration, replaced by the 2023 declaration : different composition: 2 ingredient(s) added, 3 missing
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Formule Prostate - Si miao qian lie wan: composition and regulation”, https://compoatlas.com/en/supplements/products/312530-formule-prostate-si-miao-qian-lie-wan, updated 15 November 2026.